- Report
- February 2026
- 483 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 361 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 464 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 473 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 172 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 480 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 458 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 283 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 382 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 372 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 274 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 393 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 386 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 474 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 207 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 281 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 380 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 279 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 384 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 294 Pages
Global
From €5103EUR$5,850USD£4,447GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more